Guilderland, NY, United States of America

Jon Summersett


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2011-2014

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jon Summersett: Innovator in Neuroprotection and Intraocular Pressure Management

Introduction

Jon Summersett is a notable inventor based in Guilderland, NY (US). He has made significant contributions to the field of ophthalmology, particularly in the development of treatments for elevated intraocular pressure and neuroprotection of neurological tissues. With a total of 4 patents to his name, Summersett's work is paving the way for advancements in eye care.

Latest Patents

Among his latest patents is a polymorph of brimonidine pamoate. This polymorph exhibits unique characteristics that are crucial for its application in compositions, devices, or implants aimed at treating or controlling elevated intraocular pressure. Additionally, it plays a vital role in providing neuroprotection to components of neurological tissues, specifically to prevent progressive degeneration. The implications of this invention are significant, as it can be utilized to protect cells and components of the optic nerve system.

Career Highlights

Jon Summersett is currently associated with Bausch & Lomb Incorporated, a leading company in the eye care industry. His work at Bausch & Lomb has allowed him to focus on innovative solutions that address critical issues in eye health. His expertise and dedication to research have made him a valuable asset to the company.

Collaborations

Summersett has collaborated with notable colleagues, including Hongna Wang and Stephen R Davio. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of ophthalmology.

Conclusion

Jon Summersett's contributions to the field of eye care through his patents and collaborations highlight his commitment to advancing medical technology. His work not only addresses immediate health concerns but also paves the way for future innovations in neuroprotection and intraocular pressure management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…